Showing results (101-110 of 261) with videos related to
Sort By:
Pageof 27
Plos One|July 8, 2014
In vitro palmitate treatment of myotubes from postmenopausal women leads to ceramide accumulation, inflammation and affected insulin signalingJulie Abildgaard, Darren C Henstridge, Anette T Pedersen, et al.The New England Journal of Medicine|October 28, 2011
A 52-week trial comparing briakinumab with methotrexate in patients with psoriasisKristian Reich, Richard G Langley, Kim A Papp, et al.Immunology|December 1, 1994
Human IgG subclass responses and subclass restriction to Schistosoma mansoni egg antigensJ G Langley, H C Kariuki, A P Hammersley, et al.Archives of Dermatological Research|May 28, 2009
Humanized anti-CD2 monoclonal antibody treatment of plaque psoriasis: efficacy and pharmacodynamic results of two randomized, double-blind, placebo-controlled studies of intravenous and subcutaneous siplizumabRobert Bissonnette, Richard G Langley, Kim Papp, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|October 12, 2013
Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trialR Bissonnette, S Nigen, R G Langley, et al.Journal of the American Academy of Dermatology|July 8, 2010
Long-term etanercept in pediatric patients with plaque psoriasisAmy S Paller, Elaine C Siegfried, Lawrence F Eichenfield, et al.The International Journal of Artificial Organs|November 1, 1983
Effects of serial resin hemoperfusion in fulminant hepatic failureD Bihari, R D Hughes, A E Gimson, et al.Journal of Cutaneous Medicine and Surgery|April 25, 2006
Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis: individualized patient approachesRichard G Langley, Vincent Ho, Charles Lynde, et al.Journal of Drugs in Dermatology : JDD|August 13, 2015
Secukinumab Improves Physical Function in Subjects With Plaque Psoriasis and Psoriatic Arthritis: Results from Two Randomized, Phase 3 TrialsAlice B Gottlieb, Richard G Langley, Sandra Philipp, et al.The British Journal of Dermatology|November 19, 2010
Adalimumab for moderate to severe chronic plaque psoriasis: efficacy and safety of retreatment and disease recurrence following withdrawal from therapyK Papp, J Crowley, J-P Ortonne, et al.Pageof 27